Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-11

Clinical Trial Update: Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating quetiapine XR with divalproex ER for anxiety symptoms in bipolar disorder patients with panic disorder and/or generalized anxi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Divalproex Sodium ER (divalproex sodium ER)
  • Quetiapine SR (quetiapine)

Snippet

Sponsor: University of South Florida | Conditions: Bipolar Disorder, Panic Disorder | Phase 4 | Status: COMPLETED | Results posted: 2020-06-11